• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎克雷伯氏菌的群体基因组学。

Population genomics of Klebsiella pneumoniae.

机构信息

Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia.

Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.

出版信息

Nat Rev Microbiol. 2020 Jun;18(6):344-359. doi: 10.1038/s41579-019-0315-1. Epub 2020 Feb 13.

DOI:10.1038/s41579-019-0315-1
PMID:32055025
Abstract

Klebsiella pneumoniae is a common cause of antimicrobial-resistant opportunistic infections in hospitalized patients. The species is naturally resistant to penicillins, and members of the population often carry acquired resistance to multiple antimicrobials. However, knowledge of K. pneumoniae ecology, population structure or pathogenicity is relatively limited. Over the past decade, K. pneumoniae has emerged as a major clinical and public health threat owing to increasing prevalence of healthcare-associated infections caused by multidrug-resistant strains producing extended-spectrum β-lactamases and/or carbapenemases. A parallel phenomenon of severe community-acquired infections caused by 'hypervirulent' K. pneumoniae has also emerged, associated with strains expressing acquired virulence factors. These distinct clinical concerns have stimulated renewed interest in K. pneumoniae research and particularly the application of genomics. In this Review, we discuss how genomics approaches have advanced our understanding of K. pneumoniae taxonomy, ecology and evolution as well as the diversity and distribution of clinically relevant determinants of pathogenicity and antimicrobial resistance. A deeper understanding of K. pneumoniae population structure and diversity will be important for the proper design and interpretation of experimental studies, for interpreting clinical and public health surveillance data and for the design and implementation of novel control strategies against this important pathogen.

摘要

肺炎克雷伯菌是住院患者中机会性感染的常见抗微生物药物耐药病原体。该物种天然对青霉素具有耐药性,人群中经常获得对多种抗菌药物的耐药性。然而,对肺炎克雷伯菌的生态学、种群结构或致病性的了解相对有限。在过去十年中,由于产超广谱β-内酰胺酶和/或碳青霉烯酶的多药耐药株引起的与医疗保健相关感染的流行率增加,肺炎克雷伯菌已成为主要的临床和公共卫生威胁。同时,也出现了由“高毒力”肺炎克雷伯菌引起的严重社区获得性感染的平行现象,与表达获得性毒力因子的菌株有关。这些不同的临床关注点激发了人们对肺炎克雷伯菌研究的重新关注,特别是对基因组学的应用。在这篇综述中,我们讨论了基因组学方法如何促进了我们对肺炎克雷伯菌分类学、生态学和进化以及与致病性和抗微生物药物耐药性相关的临床相关决定因素的多样性和分布的理解。深入了解肺炎克雷伯菌的种群结构和多样性对于正确设计和解释实验研究、解释临床和公共卫生监测数据以及设计和实施针对这一重要病原体的新型控制策略都非常重要。

相似文献

1
Population genomics of Klebsiella pneumoniae.肺炎克雷伯氏菌的群体基因组学。
Nat Rev Microbiol. 2020 Jun;18(6):344-359. doi: 10.1038/s41579-019-0315-1. Epub 2020 Feb 13.
2
Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health.肺炎克雷伯菌的多样性、种群结构、毒力及抗菌药物耐药性的基因组分析,对公共卫生构成紧迫威胁。
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):E3574-81. doi: 10.1073/pnas.1501049112. Epub 2015 Jun 22.
3
Antimicrobial Resistance of Hypervirulent : Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms.高毒力 耐药性:流行病学、高毒力相关决定因素和耐药机制。
Front Cell Infect Microbiol. 2017 Nov 21;7:483. doi: 10.3389/fcimb.2017.00483. eCollection 2017.
4
Genomic Diversity, Virulence, and Antimicrobial Resistance of Strains from Cows and Humans.牛源和人源 菌株的基因组多样性、毒力和抗药性。
Appl Environ Microbiol. 2019 Mar 6;85(6). doi: 10.1128/AEM.02654-18. Print 2019 Mar 15.
5
Genetic diversity, mobilisation and spread of the yersiniabactin-encoding mobile element ICEKp in Klebsiella pneumoniae populations.肠杆菌科细菌中携带耶尔森菌素的可移动元件 ICEKp 的遗传多样性、动员和传播。
Microb Genom. 2018 Sep;4(9). doi: 10.1099/mgen.0.000196. Epub 2018 Jul 9.
6
Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China.中国出现越来越多的抗微生物药物耐药性超强毒力(高黏液性)肺炎克雷伯菌分离株。
Clin Infect Dis. 2014 Jan;58(2):225-32. doi: 10.1093/cid/cit675. Epub 2013 Oct 7.
7
High mortality among patients infected with hypervirulent antimicrobial-resistant capsular type K1 Klebsiella pneumoniae strains in Taiwan.高死亡率患者感染高毒力抗微生物耐药荚膜型 K1 肺炎克雷伯菌菌株在台湾。
Int J Antimicrob Agents. 2018 Aug;52(2):251-257. doi: 10.1016/j.ijantimicag.2018.06.008. Epub 2018 Jun 12.
8
Klebsiella pneumoniae Population Genomics and Antimicrobial-Resistant Clones.肺炎克雷伯菌的群体遗传学和抗药性克隆。
Trends Microbiol. 2016 Dec;24(12):944-956. doi: 10.1016/j.tim.2016.09.007. Epub 2016 Oct 11.
9
Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.耐碳青霉烯类肺炎克雷伯菌基因组适应与进化的临床意义
J Infect Dis. 2017 Feb 15;215(suppl_1):S18-S27. doi: 10.1093/infdis/jiw378.
10
Mapping the Evolution of Hypervirulent Klebsiella pneumoniae.绘制高毒力肺炎克雷伯菌的进化图谱。
mBio. 2015 Jul 21;6(4):e00630. doi: 10.1128/mBio.00630-15.

引用本文的文献

1
Multi-omics investigation reveals unique markers in compared to closely related species.多组学研究揭示了与近缘物种相比的独特标志物。 (你提供的原文中“compared to closely related species”前缺少比较对象,我按照正常语义进行了补充翻译,如果不是你想要的,请提供完整准确的原文。)
Front Microbiol. 2025 Aug 20;16:1657680. doi: 10.3389/fmicb.2025.1657680. eCollection 2025.
2
The global genomic landscape of hypervirulent from 1932 to 2021.1932年至2021年高毒力菌株的全球基因组概况。
mLife. 2025 Aug 24;4(4):378-396. doi: 10.1002/mlf2.70029. eCollection 2025 Aug.
3
Treatment of liver abscess caused by Klebsiella pneumoniae with multi-site infection: a case report.

本文引用的文献

1
The Ecology and Evolution of Pangenomes.泛基因组的生态与进化。
Curr Biol. 2019 Oct 21;29(20):R1094-R1103. doi: 10.1016/j.cub.2019.08.012.
2
Small Plasmids: Neglected Contributors to Antibiotic Resistance.小型质粒:抗生素耐药性中被忽视的因素
Front Microbiol. 2019 Sep 20;10:2182. doi: 10.3389/fmicb.2019.02182. eCollection 2019.
3
A conjugative plasmid that augments virulence in Klebsiella pneumoniae.一种能增强肺炎克雷伯菌毒力的接合质粒。
肺炎克雷伯菌引起的多部位感染性肝脓肿的治疗:一例报告
J Med Case Rep. 2025 Aug 28;19(1):428. doi: 10.1186/s13256-025-05511-9.
4
Meropenem/vaborbactam activity against carbapenem-resistant from catheter-related bloodstream infections.美罗培南/巴硼巴坦对导管相关血流感染中耐碳青霉烯菌的活性。
Front Cell Infect Microbiol. 2025 Jul 31;15:1616353. doi: 10.3389/fcimb.2025.1616353. eCollection 2025.
5
Molecular and virulence differences of isolated from blood.从血液中分离出的[物质]的分子和毒力差异 。(注:原文中“isolated from blood”前缺少具体所指内容,翻译为“[物质]”以便使句子相对完整通顺,但确切含义需根据完整原文确定)
Front Microbiol. 2025 Jul 30;16:1650010. doi: 10.3389/fmicb.2025.1650010. eCollection 2025.
6
Cataloging variation in 16S rRNA gene sequences of female urobiome bacteria.女性泌尿微生物群细菌16S核糖体RNA基因序列变异的编目
Front Urol. 2024 Jan 8;3:1270509. doi: 10.3389/fruro.2023.1270509. eCollection 2023.
7
Ethanol Extract From the Stem Bark of Adansonia digitata L. (Baobab) Displays Therapeutic Potential Against Klebsiella pneumoniae Infection.猴面包树茎皮乙醇提取物对肺炎克雷伯菌感染具有治疗潜力。
Cureus. 2025 Jul 8;17(7):e87520. doi: 10.7759/cureus.87520. eCollection 2025 Jul.
8
Hypervirulent causing bloodstream infections in Hungary.高毒力的,在匈牙利引发血流感染。
Microbiol Spectr. 2025 Sep 2;13(9):e0003125. doi: 10.1128/spectrum.00031-25. Epub 2025 Aug 4.
9
Characterization and genomics of phage Henu2_3 against K1 Klebsiella pneumoniae and its efficacy in animal models.抗K1型肺炎克雷伯菌噬菌体Henu2_3的特性、基因组学及其在动物模型中的疗效
AMB Express. 2025 Jul 30;15(1):112. doi: 10.1186/s13568-025-01919-0.
10
Antibacterial Activity of Jelleine-I, a Peptide Isolated from Royal Jelly of , Against Colistin-Resistant .从蜂王浆中分离出的肽Jelleine-I对耐黏菌素的[具体细菌名称未给出]的抗菌活性
Toxins (Basel). 2025 Jun 25;17(7):325. doi: 10.3390/toxins17070325.
Nat Microbiol. 2019 Dec;4(12):2039-2043. doi: 10.1038/s41564-019-0566-7. Epub 2019 Sep 30.
4
Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines.撒哈拉以南非洲地区新生儿侵袭性细菌感染和抗菌药物耐药的病因学:一项基于 STROBE-NI 报告规范的系统评价和荟萃分析。
Lancet Infect Dis. 2019 Nov;19(11):1219-1234. doi: 10.1016/S1473-3099(19)30414-1. Epub 2019 Sep 12.
5
OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo.OmpK36 介导的碳青霉烯类耐药削弱了 ST258 型肺炎克雷伯菌在体内的毒力。
Nat Commun. 2019 Sep 2;10(1):3957. doi: 10.1038/s41467-019-11756-y.
6
Contrasting patterns of longitudinal population dynamics and antimicrobial resistance mechanisms in two priority bacterial pathogens over 7 years in a single center.7 年间单中心 2 种重点细菌病原体的纵向人群动态和抗菌药物耐药机制的对比模式。
Genome Biol. 2019 Sep 2;20(1):184. doi: 10.1186/s13059-019-1785-1.
7
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread.欧洲耐碳青霉烯类肺炎克雷伯菌的流行是由医院内传播驱动的。
Nat Microbiol. 2019 Nov;4(11):1919-1929. doi: 10.1038/s41564-019-0492-8. Epub 2019 Jul 29.
8
Genomics for Molecular Epidemiology and Detecting Transmission of Carbapenemase-Producing in Victoria, Australia, 2012 to 2016.2012 年至 2016 年澳大利亚维多利亚州产碳青霉烯酶的分子流行病学和传播检测的基因组学研究
J Clin Microbiol. 2019 Aug 26;57(9). doi: 10.1128/JCM.00573-19. Print 2019 Sep.
9
: an emerging pathogen in humans.一种人类中新出现的病原体。
Emerg Microbes Infect. 2019;8(1):973-988. doi: 10.1080/22221751.2019.1634981.
10
Efflux pumps AcrAB and OqxAB contribute to nitrofurantoin resistance in an uropathogenic Klebsiella pneumoniae isolate.外排泵 AcrAB 和 OqxAB 有助于泌尿道致病性肺炎克雷伯菌分离株对呋喃妥因的耐药性。
Int J Antimicrob Agents. 2019 Aug;54(2):223-227. doi: 10.1016/j.ijantimicag.2019.06.004. Epub 2019 Jun 11.